Empowered Funds LLC Has $6.79 Million Stake in AdaptHealth Corp. (NASDAQ:AHCO)

Empowered Funds LLC grew its stake in AdaptHealth Corp. (NASDAQ:AHCO) by 25.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 713,643 shares of the company’s stock after purchasing an additional 142,743 shares during the period. Empowered Funds LLC owned about 0.53% of AdaptHealth worth $6,794,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Pacer Advisors Inc. acquired a new stake in AdaptHealth in the fourth quarter valued at approximately $76,271,000. Blue Trust Inc. lifted its stake in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares in the last quarter. Moody National Bank Trust Division grew its position in AdaptHealth by 31.5% during the 4th quarter. Moody National Bank Trust Division now owns 151,170 shares of the company’s stock worth $1,439,000 after acquiring an additional 36,212 shares during the last quarter. Finally, Reinhart Partners LLC. increased its holdings in AdaptHealth by 1.1% in the 4th quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company’s stock worth $59,660,000 after purchasing an additional 68,212 shares in the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Trading Down 1.9 %

AHCO opened at $9.15 on Tuesday. AdaptHealth Corp. has a twelve month low of $7.01 and a twelve month high of $11.90. The company has a fifty day moving average of $10.01 and a 200-day moving average of $10.33. The stock has a market cap of $1.23 billion, a PE ratio of -5.55, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34.

Analyst Upgrades and Downgrades

AHCO has been the topic of a number of recent research reports. Royal Bank of Canada cut their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Truist Financial cut their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research report on Friday, November 15th. Robert W. Baird decreased their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. UBS Group cut their price target on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Finally, Canaccord Genuity Group lowered their target price on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $12.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.